aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Monteris Medical is a medical device company dedicated to developing MRI-guided, laser-based systems for the precise and controlled treatment of brain cancer. Their core mission is to provide innovative neurosurgical tools that ablate brain tumors with minimal impact on surrounding healthy tissue. The company focuses on diseases of the brain, offering advanced solutions for clinicians to improve patient outcomes.
Monteris Medical has achieved significant milestones in the field of neurosurgery, with its technologies being adopted by numerous medical institutions. Their MRI-guided laser systems have been recognized for enhancing the precision and safety of brain tumor ablation procedures. The company's impact is evident in its contribution to advancing brain cancer treatment, providing new hope for patients and healthcare professionals alike.
Operating Status
Active
Ownership Type(s)
Equity
Main Product(s)
Medical Devices
Technology
AI, Robotics
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Monteris Medical founded?
Monteris Medical was founded in 1999.
Where is Monteris Medical’s headquarters located?
Monteris Medical’s headquarters is located in Minneapolis, MN, US.
When was Monteris Medical’s last funding round?
Monteris Medical’s most recent funding round was for $38M (USD) in October 2022.
How many employees does Monteris Medical have?
Monteris Medical has 175 employees as of Feb 4, 2024.
How much has Monteris Medical raised to-date?
As of July 05, 2023, Monteris Medical has raised a total of $216.1M (USD) since Oct 27, 2022.
Add Comparison
Total Raised to Date
$216.1M
USD
Last Update Oct 27, 2022
Last Deal Details
$38M
USD
Oct 27, 2022
Debt Financing
Total Employees Over Time
175
As of Feb 2024
Monteris Medical Address
14755 27th Ave N
Minneapolis,
Minnesota
55447
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts